Viewing Study NCT04201457


Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2025-12-25 @ 4:19 PM
Study NCT ID: NCT04201457
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-04
First Post: 2019-12-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration
Sponsor: Pediatric Brain Tumor Consortium
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module